Vestmark Advisory Solutions, Inc. Catalent, Inc. Transaction History

Vestmark Advisory Solutions, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$72.36 - $113.1 $4,196 - $6,559	-58 Reduced 1.86%	3,060 $221,000
Q2 2022 Aug 04, 2022	BUY	$87.2 - $114.05 $15,434 - $20,186	177 Added 6.02%	3,118 $335,000
Q1 2022 Apr 27, 2022	BUY	$94.19 - $124.49 $8,194 - $10,830	87 Added 3.05%	2,941 $326,000
Q4 2021 Jan 31, 2022	BUY	$119.57 - $139.07 $22,718 - $26,423	190 Added 7.13%	2,854 $365,000
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $15,829 - $20,640	145 Added 5.76%	2,664 $354,000
Q2 2021 Aug 09, 2021	BUY	$100.34 - $115.69 $252,756 - $291,423	2,519 New	2,519 $272,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.